The influence of chain length and base sequence on the pharmacokinetic behavior of 99mTc-morpholinos in mice

Quarterly Journal of Nuclear Medicine

Volumn 46, Issue 3, 2002, Pages 233-243

  Liu, G ^a   Zhang, S ^a   He, J ^a   Liu, N ^a   Gupta, S ^a   Rusckowski, M ^a   Hnatowich, Donald J ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

Base sequence; Neoplasms, radionuclide imaging; Oligonucleotides; Pharmacokinetics; Technetium

Indexed keywords

CARCINOEMBRYONIC ANTIBODY; DNA; MORPHOLINE 15; MORPHOLINE 18; MORPHOLINE 25; MORPHOLINE DERIVATIVE; OLIGOMER; OLIGONUCLEOTIDE; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; HEART; IMAGING; IN VIVO STUDY; KIDNEY; LIVER; LUNG; MOUSE; MUSCLE; NONHUMAN; NUCLEAR MEDICINE; NUDE MOUSE; SEQUENCE ANALYSIS; SPLEEN; TISSUE DISTRIBUTION; TUMOR;

ANIMALS; BASE SEQUENCE; ISOTOPE LABELING; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; OLIGONUCLEOTIDES; OLIGONUCLEOTIDES, ANTISENSE; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION; TUMOR MARKERS, BIOLOGICAL;

EID: 0036750551     PISSN: 11243937     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hnatowich DJ, Pharmacokinetics considerations in the development of oligomers as radiopharmaceuticals. Q J Nucl Med 1997; 41:91-100.
2. Hnatowich DJ, Mardirossian G, Fogarasi M, Sano T, Smith CL, Cantor CR et al. Comparative properties of a technetium-99m-labeled single-stranded natural DNA and a phosphorothioate derivative in vitro and in vivo in mice. Pharm Exp Ther 1996;276:326-34.
3. DeLong RK, Nolting A, Fisher M, Chen Q, Wickstrom E, Kligshteyn M et al. Comparative pharmacokinetics, tissue distribution, and tumor accumulation of phosphorothioiate, phosphorodithioiate, and methylphosphonate oligonucleotides in nude mice. Antisense Nucleic Acid Drug Dev 1997;7:71-7.
4. Mardirossian G, Lei K, Rusckowski M, Chang F, Qu T, Egholm M et al. In vivo hybridization of technetium-99m-labeled peptide nucleic acid (PNA). J Nucl Med 1997;38:907-13.
5. 99mTc-labeled morpholinos for radiopharmaceutical applications. Eur J Nucl Med 2001;28:1682-9.
6. Iversen P. Phasphorodiamidate morpholino oligomers. In: Crooke STT, editor. Antisense drug technology. New York: Marcel Dekker, Inc.; 2001. p. 375-89.
7. 99mTc attached to antisense DNA. Eur J Nucl Med 2000;27:1700-7.
8. Hnatowich DJ. Antisense and nuclear medicine. J Nucl Med 1999;40:693-703.
9. Shafter RH, Smirnov I. Biological aspects of DNA/RNA quadruplexes. Biopoly (Nucleic Acid Sci) 2001;56:209-27.
10. Zhao Q, Temasamani J, Zhou RZ, Agrawal S. Pattern and kinetics of cytokine production following administration of phosphorothioate oligonucleotides in mice. Antisense Nucleic Acid Drug 1997;7:495-502.
11. Morasutti C, Dapas B, Scaggiante B, Paroni G, Xodo L, Quadrifoglio F. Effect of oligomer length and base substitutions on the cytotoxic activity and specific nuclear protein recognition of GTn oligonucleotides in human leukemic CCRF-CEM cell line. Nucleosides Nucleotides 1999;18:1711-6.
12. Wang G, Jiang K, Balczon R, Xu X. Defining the peptide nucleic acid (PNA) length requirement for PNA binding-induced transcription and gene expression. J Mol Biol 2001;313:933-40.
13. Crooke RM, Graham MJ, Martin MJ, Lemonidis KM, Wyrzykiewiecz T, Cummins L.L. Metabolism of antisense oligonucleotides in rat liver homogenates. J Pharm Exp Ther 2000;292:140-9.
14. Kaukinen U, Lyytikainen S, Mikkola S, Lonnberg H. The reactivity of phosphodiester bond within linear single-stranded oligoribonucleotides is strongly dependent on base sequence. Nucl Acids Res 2002;30:468-74.
15. 99mTc labeled morpholinos, a DNA analog. J Nucl Med 2002;43:284-391.
16. Wang Y, Chang F, Zhang Y, Liu N, Liu G, Gupta S et al. Pretargeting with amplification using polymeric peptide nucleic acid (PNA). Bioconj Chem 2001;12:807-16.
17. 3 for technetium-99m labeling of DNA. Nucl Med Biol 1997;24:425-32.
18. Hnatowich DJ, Mardirossian G, Rusckowski M, Winnard P Jr. Protein labeling via deoxyribonucleic acid hybridization. Nucl Med Comm 1996;17:66-75.
19. Rusckowski M, Qu T, Chang F, Hnatowich DJ. Pretargeting using peptide nucleic acid (PNA). Cancer 1997;80:2699-705.